Amarin Corp Plc (AMRN)

[alm2]

North Marjac
The Delaware proceedings-I raise this question.and put very simply .. why now do Amarin not seek injunctive relief -????
the volume of generic sales has risen clearly above the 10 percent much referred to which was lost as to patent protection in the Du case -now it seems circa30 per cent and rising - by the time case heard could be near to all of USA market thus the 90 per cent of sales for cvd indication gone
Ok if A wins treble damages - but a business destroyed- one could say the laying off of 300 reps clear evidence of that process - indeed is that the generics clear intent to destroy A business prior to outcome of case ???
I can understand why not sought in first instance until clear evidence of selling into cvd usage - that is clear now
Injunction to stop generics selling into cvd market would prevent such
Why do they not seek such ? In uk courts would be a no brainer
Alm